Mercaptopurine

Drug Details

Mercaptopurine, also known as 6-MP, is a medication primarily used to treat acute lymphoblastic leukemia (ALL), a type of cancer. It is usually prescribed in combination with other cancer treatments. Mercaptopurine is available in tablet form as a generic medication or as an oral suspension under the brand name Purixan. This drug works as an antimetabolite, specifically a nucleoside metabolic inhibitor, which interferes with the ability of cancer cells to produce genetic material. This interruption prevents cancer cells from growing and leads to their destruction. While mercaptopurine can be effective in managing ALL, it may also be used off-label for certain gastrointestinal conditions like Crohn's disease and ulcerative colitis. Patients taking this medication may experience side effects such as reduced appetite, stomach discomfort, and general malaise. It is important to discuss the potential risks and benefits of mercaptopurine with a healthcare professional, particularly when considering its use in children and young adults. Always consult your doctor, nurse, or pharmacist before starting any new medication or treatment plan.